We are live on ! Find out more
NVPX

Norwest Venture Partners XII Portfolio holdings

AUM $75.4M
1-Year Est. Return 53.35%
This Fund
S&P 500
This Quarter Est. Return
+11.73%
1 Year Est. Return
-53.35%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$46M
AUM Growth
-$40M
Cap. Flow
-$50.1M
Cap. Flow %
-108.94%
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
HCAT icon
Health Catalyst
HCAT
+$50.1M

Sector Composition

Rank Sector Weight
1 Healthcare 69.68%
2 Consumer Discretionary 30.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HCAT icon
1
Health Catalyst
HCAT
$157M
$32.1M 69.68%
876,045
-1,476,045
-63% -$50.1M
CSPR
2
DELISTED
Casper Sleep Inc.
CSPR
$14M 30.32%
1,940,576
– –

Similar funds

FFMBT
First Farmers & Merchants Bank Trust Columbia, Tennessee $75.4M AUM 6.56% 1-Year Est. Return
WM
Westpark Management Plano, Texas $75.3M AUM 22.07% 1-Year Est. Return
SMC
S. Muoio & Co New York $75.7M AUM 42.51% 1-Year Est. Return
RA
Ratos AB Stockholm, Sweden $76.4M AUM
RC
Ronit Capital London, United Kingdom $74.3M AUM 13.35% 1-Year Est. Return
PM
Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return
GI
Gavea Investimentos Rj, Brazil $77.6M AUM 64.56% 1-Year Est. Return
PIMH
Prudence Investment Management (HK) 12 Harcourt Road Central, Hong Kong $78.2M AUM 52.44% 1-Year Est. Return

Norwest Venture Partners XII's Q3 2020 Portfolio in Review

As of Q3 2020, Norwest Venture Partners XII held 2 positions worth $46M, down 47% from $86M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Norwest Venture Partners XII withdrew a net $50.1M in Q3 2020, reducing 1 holding. Its largest reduction was Health Catalyst, cutting an estimated $50.1M.

By sector, the portfolio is most concentrated in Healthcare at 70% of assets, down from 80% a quarter earlier, followed by Consumer Discretionary.

  • Norwest Venture Partners XII's biggest Q3 2020 reduction was Health Catalyst, cutting an estimated $50.1M.
  • Norwest Venture Partners XII's ten largest holdings make up 100% of its $46M portfolio in Q3 2020.
  • Norwest Venture Partners XII opened 0 new positions and closed 0 in Q3 2020.
  • Norwest Venture Partners XII's portfolio value fell 47% quarter-over-quarter to $46M.

Based on Norwest Venture Partners XII's 13F filing for Q3 2020, filed 23 Oct 2020.